SATO KODO
No ORCID on file
· 10 papers in corpus
· active 2000-2001
Frequent coauthors
- FUJII TOMOHITO 10
- SHIMIZU YASUSHI 10
- TAKAHASHI HIROO 10
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2001
When it is intended to administer an estrogen antagonist for the treatment or prevention of endometriosis and/or abnormal menstruation, it is unnecessary to administer the drug constantly and continuously throughout the period of time requi…
2000
In the case of administering an estrogen antagonist for treating or preventing endometriosis and/or menstrual abnormality, it is needless to administer the drug constantly and continuously during the period with a need of the treatment or p…
2000
In the case of administering an estrogen antagonist for treating or preventing endometriosis and/or menstrual abnormality, it is needless to administer the drug constantly and continuously during the period with a need of the treatment or p…
2000
In the case of administering an estrogen antagonist for treating or preventing endometriosis and/or menstrual abnormality, it is needless to administer the drug constantly and continuously during the period with a need of the treatment or p…
2000
In the case of administering an estrogen antagonist for treating or preventing endometriosis and/or menstrual abnormality, it is needless to administer the drug constantly and continuously during the period with a need of the treatment or p…
2000
In the case of administering an estrogen antagonist for treating or preventing endometriosis and/or menstrual abnormality, it is needless to administer the drug constantly and continuously during the period with a need of the treatment or p…